Monopar Therapeutics (NASDAQ:MNPR) Research Coverage Started at Brookline Capital Management

Share on StockTwits

Brookline Capital Management began coverage on shares of Monopar Therapeutics (NASDAQ:MNPR) in a report released on Wednesday morning, BenzingaRatingsTable reports. The brokerage issued a buy rating and a $42.00 target price on the stock.

Shares of NASDAQ MNPR opened at $9.95 on Wednesday. The firm has a fifty day moving average of $16.17. Monopar Therapeutics has a fifty-two week low of $8.35 and a fifty-two week high of $48.00.

A hedge fund recently bought a new stake in Monopar Therapeutics stock. Bank of Montreal Can acquired a new stake in Monopar Therapeutics Inc. (NASDAQ:MNPR) in the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 13,000 shares of the company’s stock, valued at approximately $216,000. Bank of Montreal Can owned approximately 0.12% of Monopar Therapeutics at the end of the most recent reporting period. 0.12% of the stock is currently owned by institutional investors and hedge funds.

About Monopar Therapeutics

Monopar Therapeutics Inc, a biopharmaceutical company, engages in developing proprietary therapeutics to enhance clinical outcomes for cancer patients in the United States. It is involved in developing Validive, a clonidine mucobuccal tablet that has completed Phase II for the treatment of chemoradiation-induced severe oral mucositis; Camsirubicin, a proprietary doxorubicin analog that is in Phase II clinical trial for the treatment of adult and pediatric solid, and blood cancers; and MNPR-101, a humanized monoclonal antibody for treating cancer.

Recommended Story: What member countries make up the G-20?

Receive News & Ratings for Monopar Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monopar Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.